| Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications N Mahmood, C Mihalcioiu, SA Rabbani Frontiers in oncology 8, 24, 2018 | 418 | 2018 |
| Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications G Chen, N Shukeir, A Potti, K Sircar, A Aprikian, D Goltzman, SA Rabbani Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 374 | 2004 |
| Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis L Devy, L Huang, L Naa, N Yanamandra, H Pieters, N Frans, E Chang, ... Cancer research 69 (4), 1517-1526, 2009 | 371 | 2009 |
| Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. SA Rabbani, AP Mazar, SM Bernier, M Haq, I Bolivar, J Henkin, ... Journal of Biological Chemistry 267 (20), 14151-14156, 1992 | 305 | 1992 |
| Urokinase Overproduction Results in Increased Skeletal Metastasis by Prostate Cancer Cells in Vivo A Achbarou, S Kaiser, G Tremblay, LG Ste-Marie, P Brodt, D Goltzman, ... Cancer research 54 (9), 2372-2377, 1994 | 299 | 1994 |
| DNA methylation and breast cancer M Szyf, P Pakneshan, SA Rabbani Biochemical pharmacology 68 (6), 1187-1197, 2004 | 297 | 2004 |
| Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation G Chen, K Sircar, A Aprikian, A Potti, D Goltzman, SA Rabbani Cancer 107 (2), 289-298, 2006 | 288 | 2006 |
| The role of the plasminogen activation system in angiogenesis and metastasis SA Rabbani, AP Mazar Surgical oncology clinics of North America 10 (2), 393-415, 2001 | 243 | 2001 |
| Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis P Pakneshan, M Szyf, R Farias-Eisner, SA Rabbani Journal of Biological Chemistry 279 (30), 31735-31744, 2004 | 237 | 2004 |
| A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo P Khalili, A Arakelian, G Chen, ML Plunkett, I Beck, GC Parry, F Donate, ... Molecular cancer therapeutics 5 (9), 2271-2280, 2006 | 230 | 2006 |
| An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells SA Rabbani, J Desjardins, AW Bell, D Banville, A Mazar, J Henkin, ... Biochemical and biophysical research communications 173 (3), 1058-1064, 1990 | 222 | 1990 |
| A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo H Jallal, ML Valentino, G Chen, F Boschelli, S Ali, SA Rabbani Cancer research 67 (4), 1580-1588, 2007 | 198 | 2007 |
| Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo N Shukeir, P Pakneshan, G Chen, M Szyf, SA Rabbani Cancer research 66 (18), 9202-9210, 2006 | 196 | 2006 |
| Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo B Ateeq, A Unterberger, M Szyf, SA Rabbani Neoplasia 10 (3), 266-278, 2008 | 160 | 2008 |
| Regulation of DNA methylation in human breast cancer: effect on the urokinase-type plasminogen activator gene production and tumor invasion Y Guo, P Pakneshan, J Gladu, A Slack, M Szyf, SA Rabbani Journal of Biological Chemistry 277 (44), 41571-41579, 2002 | 159 | 2002 |
| A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo Y Guo, AAR Higazi, A Arakelian, BS Sachais, D Cines, RH Goldfarb, ... The FASEB Journal 14 (10), 1400-1410, 2000 | 157 | 2000 |
| Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA) S Rabbani, P Harakidas, DJ Davidson, J Henkin, AP Mazar International journal of cancer 63 (6), 840-845, 1995 | 156 | 1995 |
| Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets B Stefanska, D Cheishvili, M Suderman, A Arakelian, J Huang, M Hallett, ... Clinical Cancer Research 20 (12), 3118-3132, 2014 | 155 | 2014 |
| Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. SA Rabbani, RH Xing International journal of oncology 12 (4), 911-931, 1998 | 152 | 1998 |
| Circulating concentrations of parathyroid hormone‐like peptide in malignancy and in hyperparathyroidism JE Henderson, C Shustik, R Kremer, SA Rabbani, GN Hendy, D Goltzman, ... Journal of Bone and Mineral Research 5 (2), 105-113, 1990 | 152 | 1990 |
David GoltzmanAntoine J Massabki Professor of Medicine and Physiology, McGill UniversityVerified email at mcgill.ca
